Randomized double-blinded, placebo-controlled clinical trial of famciclovir for reduction of Ménière's disease symptoms

Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 6, 2004, Pages 877-884

  Derebery, M Jennifer ^a   Fisher, Laurel M ^a   Iqbal, Zarina ^a  

^a HOUSE EAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEARING DISORDER; HUMAN; MALE; MENIERE DISEASE; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; VERTIGO;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; DIZZINESS; DOUBLE-BLIND METHOD; FEMALE; HEARING DISORDERS; HERPES SIMPLEX; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; PILOT PROJECTS; VERTIGO;

EID: 9644303118     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2004.08.012     Document Type: Article

References (20)

1. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Mnire's disease American Academy of Otolaryngology-Head and Neck Foundation, Inc Otolaryngol Head Neck Surg 113 1995 181 185
2. G.P. Jacobson, C.W. Newman The development of the Dizziness Handicap Inventory Arch Otolaryngol Head Neck Surg 116 1990 424 427
3. A. Quaranta, F. Marini, V. Sallustio Long-term outcome of Mnire's disease endolymphatic mastoid shunt versus natural history Audiol Neurootol 3 1998 54 60
4. J. Claes, P.H. Van De Heyning A review of medical treatment for Mnire's disease Acta Otolaryngol Suppl 544 2000 34 39
5. E. Calenoff, J.C. Zhao, E.L. Derlacki Patients with Mnire's disease possess IgE reacting with herpes family viruses Arch Otolaryngol Head Neck Surg 121 1995 861 864
6. D.B. Welling, R.L. Daniels, J. Brainard Detection of viral DNA in endolymphatic sac tissue from Mnire's disease patients Am J Otol 15 1994 639 643
7. W. Arnold, H.P. Niedermeyer Herpes simplex virus antibodies in the perilymph of patients with Meniere disease [see comments] Arch Otolaryngol Head Neck Surg 123 1997 53 56
8. F.H. Linthicum Herpes simplex virus DNA in endolymphatic sacs in patients with Mnire's disease The Registry 2001/ 9 2002 1 4
9. S.L. Sacks, B. Wilson Famciclovir/penciclovir Adv Exp Med Biol 458 1999 135 147
10. K.S. Gill, M.J. Wood The clinical pharmacokinetics of famciclovir Clin Pharmacokinet 31 1996 1 8
11. C. Perry, A. Wagstaff Famciclovir a review of its pharmacological properties and therapeutic efficacy in herpes virus infections Drugs 50 1995 396 415
12. C.W. Newman, G.P. Jacobson, J.B. Spitzer Development of the Tinnitus Handicap Inventory Arch Otolaryngol Head Neck Surg 122 1996 143 148
13. R.E. Nisbett, T.D. Wilson Telling more than we can know verbal reports on mental processes Psychol Rev 84 1977 231 259
14. V. Arbusow, D. Teil, M. Strupp HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth Audiol Neurootol 6 2001 259 262
15. A.M. Thackray, H.J. Field Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency J Infect Dis 173 1996 291 299
16. A. Wald, J. Zeh, S. Selke Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons N Engl J Med 342 2000 844 850
17. R.J. Whitley, D.W. Kimberlin, B. Roizman Herpes simplex viruses Clin Infect Dis 26 1998 541 553 quiz 554-5
18. N.M. Sawtell, R. Thompson, R. Stanberry Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo J Infect Dis 184 2001 964 971
19. A.M. Thackray, H.J. Field Further evidence from a murine infection model that famciclovir interferes with the establishment of HSV-1 latent infections J Antimicrob Chemother 45 2000 825 833
20. D. Tucci, J. Farmer, R. Kitch Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir Otol Neurootol 23 2002 301 308